[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100600403":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":26,"centralContacts":31,"locations":26,"responsibleParty":37,"collaborators":26,"id":39,"slug":40,"hasResults":41,"nctId":42,"briefTitle":43,"officialTitle":44,"acronym":26,"eligibilityCriteria":45,"healthyVolunteers":46,"sex":47,"minAge":48,"maxAge":49,"enrollmentInfo":50,"targetDuration":26,"studyType":53,"phases":54,"briefSummary":56,"conditions":57,"keywords":59,"overallStatus":61,"whyStopped":26,"lastUpdateSubmitDate":62,"lastUpdatePostDateStruct":63,"startDateStruct":66,"completionDateStruct":68,"leadSponsor":70,"locationsCount":26},{"fullName":5,"class":6},"Henan Provincial People's Hospital","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Oliceridine group","EXPERIMENTAL","Intraoperative analgesia: Oliceridine 0.015mg\u002Fkg",[13],"Drug: Oliceridine",{"label":15,"type":16,"description":17,"interventionNames":18},"Oxycodone group","ACTIVE_COMPARATOR","Intraoperative analgesia oxycodone 0.04mg\u002Fkg",[19],"Drug: Oxycodone",[21,27],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"DRUG","Oliceridine","Intraoperative analgesia should be administered with Oliceridine",[9],null,{"type":22,"name":28,"description":29,"armGroupLabels":30,"otherNames":26},"Oxycodone","Oxycodone is used for intraoperative analgesia",[15],[32],{"name":33,"role":34,"phone":35,"phoneExt":26,"email":36},"Ningning Fu","CONTACT","8618790658707","736508728@qq.com",{"type":38,"investigatorFullName":26,"investigatorTitle":26,"investigatorAffiliation":26,"oldNameTitle":26,"oldOrganization":26},"SPONSOR","100600403","analgesic-effect-and-safety-of-oliceridine-and-oxycodone-in-vitrectomy-100600403",false,"NCT07097038","Analgesic Effect and Safety of Oliceridine and Oxycodone in Vitrectomy","Analgesic Effect and Safety of Oliceridine and Oxycodone in Vitrectomy: a Randomized Controlled Trial","Inclusion Criteria:\n\n* Age 18-75 years old, ASA Ⅰ - Ⅱ (the age of patients with vitreous surgery can be relaxed to 75 years old, and serious systemic diseases need to be excluded);\n* Vitrectomy with local anesthesia (retrobulbar \u002F peribulbar block) combined with intravenous sedation and analgesia (such as maculopathy, retinal detachment, etc.);\n* Preoperative VAS score ≤ 3, can cooperate with pain and sedation score;\n* Signed informed consent.\n\nExclusion Criteria:\n\n* Be allergic to test drugs or opioids, or have a history of opioid abuse;\n* Severe cardiopulmonary disease (such as heart failure, COPD), liver and kidney dysfunction (alt\u002Fast \\> 3 times normal, creatinine \\> 177 μ mol\u002Fl);\n* Glaucoma (avoiding the risk of fluctuation of intraocular pressure), sinus bradycardia (\\\u003C 50 beats \u002F min, preventing aggravation of oculo cardiac reflex);\n* Used analgesic \u002F sedative drugs within 24 hours before surgery;\n* Those who are unable to cooperate due to mental illness or cognitive impairment.",true,"ALL","18 Years","75 Years",{"count":51,"type":52},120,"ESTIMATED","INTERVENTIONAL",[55],"NA","Traditional opioid analgesia is a method to treat moderate to severe pain. However, the use of opioids is not without risks. When treating acute pain, patients may have hypotension, respiratory depression, hypoxia, nausea and vomiting, irritability and pruritus. The aim of this study was to evaluate the analgesic effect and safety of g-protein-biased μ - opioid receptor agonists Oliceridine and oxycodone in vitrectomy.",[58],"Vitrectomy",[60],"Basic anesthesia","NOT_YET_RECRUITING","2025-07-30",{"date":64,"type":65},"2025-07-31","ACTUAL",{"date":67,"type":52},"2025-07",{"date":69,"type":52},"2026-07",{"name":5,"class":6}]